Clinical Trial Search

Primary: Safey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After Resurfacing — 1.33; 3.00; 0; 0 units on a scale

Primary: Overall Improvement of Acne Scarring — 2.26; 1.91 units on a scale

Primary: MMSS for Scar Halves Treated — 8.4; 8.7 score on a scale

Primary: Photographic Knee Laxity and Texture Evaluation — 1.87; 2.02 score on a scale

Primary: Mean Change From Baseline in Erythema — -1.687; 5.730 units on a scale

Primary: Overall Wrinkle Improvement Assessed by the Fitzpatrick Wrinkle and Elastosis Scale (FWES) at 12 Weeks Post-Final Treatment — 5.97; 5.78 units on a scale

Primary: Physician's Global Assessment of Improvement — 2 score on a scale

Primary: Complete Clearance (%) of Actinic Keratoses (AKs) — 81; 60 percentage (%) of AK clearance

Primary: Change in Aesthetics — 2; 1 score on a scale

Primary: Improvement in Acne Scarring - From Baseline to Three Months After Last Treatment — 2; 2 score on a scale

Primary: Pigmented Lesion Improvement by Blinded Evaluation — 41 observations

Primary: Independent Photo Reviewer Fitzpatrick Wrinkle and Elastosis Scale (FWS) — 55 Participants — p=<.0001

Primary: Scar Pain — 1.265; 1.181; 1.048; 1.084 units on a scale — p=0.0492

Primary: Mean Improvement in Photoaging Damage Appearance at 3 Months Post Treatment — 2.81 units on a scale

Primary: Contracture of Scar Surface Area (Percentage of Original Area) — 97; 97 percentage

Primary: Changes in Facial Scarring Score — -.50 score on a scale

Primary: Percentage of Participants With Facial Acne Improvement Using the Global Aesthetic Improvement Scale — 28.6; 57.1; 14.3 percentage of participants

Primary: Improvement in Fitzpatrick Wrinkle and Elastosis Scale (FWS) Score — 51 Participants

Primary: Acne Scar Improvement — 0.26 units on a scale

Primary: Analysis of Elasticity (Collagen & Elastin) — 1.7; 0.5; 1.5; 0.5 units on a scale

Primary: Improvement in Fine Lines — 1.77 Scores on a scale

Primary: Difference in Basal Layer Keratinocytes Positive for Both Ki67 and Thymine Dimers — 21.5; 14.7 positive cells/1000 basal layer cells

Primary: Subject Satisfaction — 3.5 units on a scale

Primary: Change in Dyspigmentation Spots — 48.3; 46; 42.2; 42.5 Dyspigmentation Spots

Primary: Change in Spots - Front of Face (Part 1) — 53.60; 58.47; 56.44 spots

Primary: Patient Observer Scar Assessment Scale (POSAS) — 17.69; 11.2; 15.2; 11.4 units on a scale — p=0.019

Primary: Overall Acne Scar Improvement Assessed by the Global Aesthetic Improvement Scale (GAIS) at 12 Weeks. — 1.06; 0.85 score on a scale

Primary: Degree of Improvement in Erythematotelangiectatic Rosacea and Papulopustular Rosacea — 2.114; 2.088 score on a scale

Primary: Change in Scar Pliability Between the Treated and Control Incision Sites as Measured by Skin Elasticity at 6 Months Compared to Baseline

Primary: Improvement of Surgical Scars at 12 Months Compared to Baseline (Pre-treatment) as Evaluated by 3 Independent Blinded Reviewers Using the General Aesthetic Improvement…